InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Moran Susan. Officer active across 2 companies, notably RayzeBio, Inc.. Cumulatively, 4 disclosures have been recorded. Activity tracked since 22 January 2024. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Moran Susan is linked to BioAtla, Inc. as Director and to RayzeBio, Inc. as CHIEF MEDICAL OFFICER. She has 4 filings in total, and in the 4 recently observed filings, the reported sell volume totals EUR 18683772, with filings dated from 2024-02-06 to 2025-06-18. The modal transaction nature is Attribution.